D23.39 represents a specific diagnostic classification for a non-cancerous (benign) growth of the skin located on various anatomical areas of the face, excluding the lips, eyelids, and ears. This code encompasses a broad range of skin neoplasms that arise from the epidermis or skin appendages, such as hair follicles, sebaceous glands, or eccrine and apocrine sweat glands. Common clinical entities captured by this code include seborrheic keratoses, benign squamous papillomas, epidermal cysts, and various skin adnexal tumors like syringomas, trichoepitheliomas, and pilomatricomas when they occur on the forehead, cheeks, chin, or temples. While these lesions are benign and do not possess metastatic potential, they are frequently evaluated to rule out malignancies like basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma, particularly if they exhibit growth, irregular borders, or pigmentary changes. Management is typically conservative, though excision or destruction may be indicated for symptomatic relief of irritation, diagnostic confirmation via histopathology, or patient-preferred cosmetic removal.
Document the exact anatomical sub-site of the face such as the forehead, cheek, chin, or temple to distinguish the lesion from specifically coded areas like the eyelid or lip.
Example: Patient presents for evaluation of a 1.2 cm firm dermal nodule on the right cheek. The lesion is mobile and non-tender, clinically consistent with a benign adnexal tumor. Patient has a comorbid condition of Morbid Obesity (E66.01) with a BMI of 42. Site: Right cheek. Plan: Excision to confirm benign nature. Laterality: Right cheek. Complexity: High risk due to potential for infection in skin folds.
Billing Focus: Documentation of the specific sub-site (cheek) and laterality (right) supports the use of D23.39 rather than the unspecified D23.30.
Provide detailed morphological characteristics including size, color, texture, and borders to support the medical necessity of surgical or destructive procedures.
Example: Examination of the left temple reveals a 0.8 cm pedunculated, flesh-colored papule with smooth borders and no pigmentary changes. Patient has a personal history of Malignant Melanoma (Z85.820). Site: Left temple. Appearance: Pedunculated benign skin neoplasm. Procedure: Shave removal for both cosmetic and diagnostic verification.
Billing Focus: Detailed morphology and size (0.8 cm) justify the CPT code selection for excision or destruction based on lesion diameter.
Clearly differentiate between benign neoplasms and other skin conditions like cysts or seborrheic keratoses in the assessment to ensure correct ICD-10-CM chapter selection.
Example: Patient has a 2.0 cm soft mass on the chin. Clinical presentation is more consistent with a benign skin neoplasm than an epidermal cyst as there is no central punctum. Patient also has Type 2 Diabetes Mellitus with Diabetic Chronic Kidney Disease (E11.22). Site: Chin. Assessment: Benign neoplasm of skin of chin.
Billing Focus: Explicitly ruling out cysts (L72 category) ensures the correct application of the D23 category for neoplasms.
Specify if the lesion is obstructing vision or causing functional impairment if it is located near the periorbital area but still on the cheek or temple.
Example: A 1.5 cm benign neoplasm on the left upper cheek near the infraorbital rim is causing mild visual field obstruction when the patient looks down. Patient is on long-term anticoagulant therapy (Z79.01) for Atrial Fibrillation (I48.91). Site: Left upper cheek. Symptom: Visual interference. Plan: Surgical excision.
Billing Focus: Functional impairment (visual obstruction) provides strong medical necessity for surgical intervention in the facial region.
If histopathology has been performed, document the specific type of benign neoplasm (e.g., dermatofibroma, hidrocystoma) to support the highest level of specificity.
Example: Biopsy results from the right forehead lesion confirm a benign dermatofibroma. Patient has a history of Tobacco Use (Z72.0). Site: Right forehead. Pathology: Dermatofibroma (benign). Plan: Clinical monitoring. Laterality: Right forehead.
Billing Focus: Linking the pathology report findings to the clinical note reinforces the accuracy of the D23.39 diagnosis code.
Used for the initial evaluation of a new skin lesion of the face where the MDM is low.
Standard for follow-up of a known benign lesion or post-procedural check-up.
Direct surgical treatment for small benign neoplasms of the face.
Surgical removal of mid-sized benign lesions on facial 'other' sites.
Used to obtain a tissue sample when the diagnosis of a benign facial neoplasm is uncertain.
Used for non-excisional removal of benign neoplasms like seborrheic keratoses on the face.
Used for closure after excision of a benign neoplasm from the face.
Used for obtaining a full-thickness sample of a facial lesion for pathological review.
Used when the management of a benign lesion is complicated by multiple comorbidities or high patient anxiety.
Necessary for large or deep benign neoplasms on the face where a punch biopsy is insufficient.